GlassScriptPhysician profile
Josiah D Nelson
NPI 1376595074
$12,512.12
in general payments reported to CMS, 2019-2025
41 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $2,829 · 2021: $1,170 · 2022: $3,040 · 2023: $588 · 2024: $3,431 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,923 · Travel and Lodging: $1,883 · Honoraria: $175 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,923.05 |
| Travel and Lodging | $1,883.32 |
| Honoraria | $175.00 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,259.65 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $1,465.16 | 2020-2024 | Axonics, Bulkamid |
| Neotract INC. | $1,378.90 | 2020 | |
| Procept Biorobotics Corporation | $1,127.56 | 2019-2025 | |
| Blue Earth Diagnostics | $800.44 | 2020-2025 | Posluma |
| Janssen Biotech, INC. | $679.82 | 2019-2025 | Erleada, Akeega |
| Intuitive Surgical, INC. | $306.61 | 2019-2024 | |
| Boston Scientific Corporation | $287.70 | 2019-2025 | Axonics, Rezum Generator, Spaceoar Vue System - 10ml |
| Coloplast Corp | $213.33 | 2019-2025 | Speedicath, Altis |
| Astellas Pharma US INC | $212.27 | 2019-2025 | Xtandi |
| Lumenis, INC | $173.00 | 2020 | |
| Pfizer INC. | $149.81 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $145.81 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $115.09 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.35 | 2021-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $110.06 | 2024-2025 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $105.49 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $97.83 | 2019-2025 | Provenge |
| Profound Medical Corp. | $88.64 | 2025 | Tulsa-Pro |
| Myovant Sciences INC. | $70.08 | 2021-2022 | |
| Urogen Pharma, INC. | $60.58 | 2021-2025 | Jelmyto |
| Endo USA, INC. | $44.90 | 2024-2025 | Aveed, Xiaflex |
| Urovant Sciences INC | $43.67 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $43.57 | 2020-2021 | |
| Allergan, INC. | $41.64 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $41.33 | 2019-2023 | Xiaflex |
| Accord Healthcare, INC. | $40.94 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $40.71 | 2023-2024 | |
| Amgen INC. | $30.48 | 2019-2023 | Prolia |
| Merck Sharp & Dohme LLC | $29.94 | 2024 | Welireg, Keytruda |
| Genzyme Corporation | $29.69 | 2021 | |
| Olympus America INC. | $20.36 | 2024 | Itind System |
| Laborie Medical Technologies Corp. | $20.22 | 2024 | Endosheath Technology |
| Karl Storz Endoscopy-America | $19.51 | 2019 | |
| Convatec INC. | $19.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.39 | 2025 | Lynparza |
| Koelis INC. | $15.73 | 2024 | |
| Tolmar, INC. | $15.28 | 2023 | |
| Antares Pharma, INC. | $14.55 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.53 | 2024 | Adstiladrin |
| Photocure INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josiah Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.